AGF Investments LLC’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-1,393
Closed -$117K 455
2021
Q1
$117K Sell
1,393
-424
-23% -$35.8K 0.01% 305
2020
Q4
$166K Buy
1,817
+104
+6% +$8.63K 0.02% 291
2020
Q3
$137K Sell
1,713
-6,452
-79% -$503K 0.02% 349
2020
Q2
$564K Sell
8,165
-769
-9% -$54.6K 0.06% 289
2020
Q1
$562K Sell
8,934
-2,169
-20% -$156K 0.07% 246
2019
Q4
$863K Sell
11,103
-1,416
-11% -$111K 0.16% 240
2019
Q3
$918K Sell
12,519
-3,744
-23% -$263K 0.22% 113
2019
Q2
$1M Sell
16,263
-645
-4% -$39K 0.21% 127
2019
Q1
$1.08M Buy
16,908
+10,947
+184% +$625K 0.24% 113
2018
Q4
$304K Buy
5,961
+3,390
+132% +$172K 0.04% 256
2018
Q3
$149K Sell
2,571
-7,776
-75% -$380K 0.02% 276
2018
Q2
$502K Buy
+10,347
New +$483K 0.06% 240
2017
Q1
Sell
-1,746
Closed -$56K 776
2016
Q4
$56K Buy
+1,746
New +$56.6K 0.01% 213

Other funds holding EW

AGF Investments LLC's EW Position: Q2 2021 in Review

AGF Investments LLC sold out of Edwards Lifesciences (EW) in Q2 2021, closing a stake of 1,393 shares — an estimated $117K sold.

AGF Investments LLC first reported a position in EW in Q4 2016 and held it in 13 quarters. The position peaked at $1.08M in Q1 2019. 1,188 funds tracked by Wall St. Rank hold EW as of Q2 2021.

  • AGF Investments LLC reported no remaining Edwards Lifesciences position as of Q2 2021 after selling out during the quarter.
  • AGF Investments LLC sold 1,393 Edwards Lifesciences shares in Q2 2021, an estimated $117K.
  • AGF Investments LLC first reported a position in Edwards Lifesciences in Q4 2016 and held it in 13 quarters.
  • AGF Investments LLC's Edwards Lifesciences position peaked at $1.08M in Q1 2019.
  • 1,188 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2021.

Based on AGF Investments LLC's 13F filing for Q2 2021, filed 12 Aug 2021.